Johnson Pharmacare Ltd (JOHNPHARMA) is currently trading at 0.54 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Johnson Pharmacare Limited is a publicly listed company (CIN L51100GJ1994PLC022388) that changed its main objects to pharmaceutical activity in 2021 but continues to report trading in goods, services, shares and investments, with registered offices in Ahmedabad and recent filings dated August 13, 2026 reflecting transitional corporate positioning and limited operating disclosure. The company reported an unaudited net loss of ₹110.31 lakhs for the quarter ended 30 June 2026, with the prior quarter showing a substantially larger loss of ₹5,561.06 lakhs and a total annual loss of ₹5,573.39 lakhs; reported full-year revenue was small at ₹158.10 lakhs audited, signaling very limited scale of core operations. Financial tension is evident: quarterly finance costs of ₹106.17 lakhs materially erode operating results and exceptional items dominate reported losses, while earnings per share remain negative at (₹0.02) for the quarter and (₹1.01) for the year, indicating continued capital and profitability stress requiring near-term remediation. External review flagged accounting presentation concerns: the statutory reviewer emphasised that the unaudited results were not prepared in strict conformity with Ind AS, even though no material misstatement was identified in limited review procedures, raising governance and reporting risk that Johnson Pharmacare Limited must address to restore financial transparency and investor confidence.

Over the past 52 weeks, Johnson Pharmacare Ltd has traded between a low of ₹0.36 and a high of ₹0.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Johnson Pharmacare Ltd has a market capitalization of approximately 29.70. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Johnson Pharmacare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -0.52 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 29.70 Cr, Johnson Pharmacare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Johnson Pharmacare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Johnson Pharmacare Ltd is -0.52. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The main announcement is the 'Biopharma Shakti' scheme, with an outlay of Rs. 10,000 crores over five years to make India a global hub for biopharmaceutical manufacturing, focusing on biologics and biosimilars.